Reports for PRO DOC LIMITEE
Company Name
PRO DOC LIMITEE
Shortage reports
Actual shortage:
10 (3%)
Anticipated shortage:
0 (0%)
Avoided shortage:
7 (2%)
Resolved:
329 (95%)
346
Discontinuation Reports
To be discontinued:
1 (1%)
Discontinued:
144 (97%)
Reversed:
4 (3%)
149
16 (3%)
6 (55%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| RANITIDINE - 150 | 150MG | TABLET | Resolved | 2017-06-28 | 2017-10-30 | 14189 |
| RANITIDINE - 150 | 150MG | TABLET | Resolved | 2019-09-19 | 2020-07-23 | 94391 |
| RANITIDINE - 300 | 300MG | TABLET | Resolved | 2017-07-26 | 2017-08-04 | 17351 |
| RANITIDINE - 300 | 300MG | TABLET | Resolved | 2019-09-19 | 2020-07-23 | 94394 |
| REPAGLINIDE | 0.5MG | TABLET | Resolved | 2018-01-05 | 2019-01-12 | 35070 |
| REPAGLINIDE | 0.5MG | TABLET | Resolved | 2018-07-11 | 2019-01-12 | 55397 |
| REPAGLINIDE | 2MG | TABLET | Resolved | 2018-11-08 | 2019-02-19 | 66478 |
| REPAGLINIDE | 1MG | TABLET | Resolved | 2018-11-12 | 2019-01-31 | 66646 |
| REPAGLINIDE | 1MG | TABLET | Resolved | 2020-01-07 | 2020-01-18 | 102499 |
| REPAGLINIDE | 2MG | TABLET | Resolved | 2024-10-04 | 2024-10-21 | 239381 |
| REPAGLINIDE | 0.5MG | TABLET | Resolved | 2024-10-04 | 2024-10-21 | 239378 |
| RIVASTIGMINE | 1.5MG | CAPSULE | Resolved | 2024-11-29 | 2025-04-05 | 244187 |
| RIVASTIGMINE | 3MG | CAPSULE | Resolved | 2024-11-29 | 2025-04-05 | 244190 |
| RIVASTIGMINE | 6MG | CAPSULE | Avoided shortage | 2024-11-29 | 2025-04-04 | 244195 |
| RIVASTIGMINE | 4.5MG | CAPSULE | Resolved | 2024-09-04 | 2025-04-05 | 236658 |
| RIVASTIGMINE | 4.5MG | CAPSULE | Resolved | 2017-03-14 | 2017-03-24 | 2307 |
| RIZATRIPTAN RDT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-07-28 | 2017-10-12 | 17458 |
| RIZATRIPTAN RDT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2018-05-07 | 2018-10-19 | 48666 |
| SERTRALINE-100 | 100.0MG | CAPSULE | Resolved | 2018-05-22 | 2018-06-07 | 49948 |
| SERTRALINE-100 | 100.0MG | CAPSULE | Resolved | 2019-08-14 | 2019-08-31 | 91502 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| RIVASTIGMINE | 4.5MG | CAPSULE | Discontinued | 2025-04-04 | 2025-04-05 | 254240 |
| RIVASTIGMINE | 6MG | CAPSULE | To be discontinued | 2025-04-04 | 2025-04-04 | 254243 |
| TEMAZEPAM-15 | 15MG | CAPSULE | Discontinued | 2017-05-08 | 2017-05-08 | 9551 |
| TEMAZEPAM-30 | 30MG | CAPSULE | Discontinued | 2017-05-08 | 2017-05-08 | 9554 |
| TERAZOSIN-2 | 2MG | TABLET | Discontinued | 2021-06-25 | 2021-08-12 | 141500 |
| TERAZOSIN-5 | 5MG | TABLET | Discontinued | 2021-06-25 | 2021-07-28 | 141503 |
| TRAMADOL-ACET | 37.5MG 325MG | TABLET | Discontinued | 2019-07-24 | 2019-09-12 | 89923 |
| ZOLMITRIPTAN | 2.5MG | TABLET | Discontinued | 2021-04-07 | 2021-04-08 | 137050 |
| ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-04-02 | 2021-04-03 | 136790 |